12 Stocks Jim Cramer Says Make Terrible Shorts

On Jim Cramer’s Mad Money, he has been talking a lot about why the US markets are still relatively strong in spite of the state of the rest of the rest of world’s economies. A big reason for the buoyancy of the markets is the work of the Federal Reserve. As Cramer explains, when the Fed Reserve cuts interest rates so low that most dividend yields are greater, investors can move to larger cap dividend-yielding stocks, bolstering the markets. This may not have been Federal Reserve Chief Ben Bernanke’s intention, but it is the result. In that environment, if you try to go bearish and shirt the market, you could lose big.

Jim Cramer

Aside from anything else – some stocks are virtually recession-resistant. They are the brands and companies that can weather a storm because of their industries or a unique product. Apple, Inc. (AAPL) is one of those stocks. People still buy those products regardless what is happening in the economy. How else could AAPL sell over one million iPhone 4S’s on the first day? As Cramer puts it, they are “hardly hostage to anything, let alone Europe.” They are companies “trade on yield, not earnings” or that already have full order books. In any case, they are the stocks that Cramer says make “terrible shorts.”

Here are 12 stocks Jim Cramer says make terrible shorts:

Cramer calls Exxon Mobil Corp (XOM) “a terrific play on the price of energy.” As he puts it, “Brent Crude is not coming down.” XOM is a favorite pick of Ken Fisher. He keeps over $584 million of his Fisher Asset Management fund invested in XOM.

Next up, take Johnson & Johnson (JNJ), Merck (MRK) and Pfizer (PFE). They are huge drug companies that are slow and consistent, so much so that they are practically like bonds that offer a little greater dividend yield on the upside. It’s no wonder that they are so popular with hedge funds. For instance, Warren Buffett has $2.8 billion of Berkshire Hathaway invested in JNJ. Merck is popular with Ric Dillon, who has more than 2% of his Diamond Hill Capital fund invested in the company. Pfizer also warrants heavy stakes. David Einhorn has over 10% of his Greenlight Capital fund invested in PFE.

Then you have companies like Boeing (BA), United Technologies (UTX) and Caterpillar (CAT). They have full order books. Sure something could happen, but is it likely? – No. Ken Fisher’s Fisher Asset Management fund has a $381.9 million stake in BA. Coming second amongst funds we track is Phill Gross and Robert Atchinson’s Adage Capital Management. Over $149 million of that fund’s portfolio is invested in BA. Both Ken Fisher and Ric Dillon are bullish about UTX. Their funds have $555 million and $261.6 million positions in the company, respectively. Ken Fisher’s fund is also invested heavily in CAT. It holds a $480.3 million share. Adage Capital is also a fan of CAT. It carries a $136.7 million position in the company

Then there are companies like Intel (INTC), Microsoft (MSFT) and Cisco (CSCO). They may be low but they also have decent enough yields that they make terrible shorts. They also have some interest from the hedge fund world’s biggest players. Ken Fisher is there again. His fund has over $431 million invested in INTC. MSFT fares just as well. Ken Fisher’s fund has a $464 million stake in the company, while Boykin Curry keeps more than $498 million of his Eagle Capital Management fund invested in MSFT. CSCO also gets a fair amount of attention from fund managers. Jean-Marie Eveillard has more than $483 million of his First Eagle Investment fund in CSCO.

Lastly, there are the stocks of Verizon (VZ) and AT&T (T). They just are not stocks that investors can short based on issues in Europe. Adage Capital is a fan of VZ, as is Jim Simons. He has more than $114 million of his Renaissance Technologies fund invested in VZ. Adage Capital is also bullish about AT&T. It has a $318 million position in the company.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!